遗传性卵巢癌综合征患者性健康优先事项调查
该横断面调查在妇科肿瘤门诊纳入75例遗传性乳腺癌卵巢癌综合征高风险患者,发现88%认为性健康重要、76%希望医疗团队介入,80%偏好医生主导讨论,且多数欢迎在降风险手术前后多个时间点沟通。
要点
- 88%患者认为性健康重要,76%希望医疗团队处理该议题。
- 80%偏好与医生讨论性健康,61%欢迎术前、89%欢迎随访期沟通。
- 35%认为在致病性变异诊断时讨论性健康过于沉重。
核心结论
- 性健康是遗传性乳腺癌卵巢癌高风险患者的重要关切,多数偏好医生主导的多阶段沟通。
研究设计与样本
- 2023年2月至11月在妇科肿瘤门诊开展的横断面调查,81例中75例(93%)完成26题问卷。
主要发现
- 中位年龄42岁(IQR 13.5),46例(61%)曾行降风险手术,22例(29%)有乳腺癌史。
- 26例(35%)认为在致病性变异诊断时讨论性健康过于沉重。
- 关键兴趣包括降风险治疗的后果(58例,77%)及维持性欲与亲密关系的策略(49例,65%)。
临床怎么用
- 对此类患者应主动、以患者为中心地在术前及随访等多个时间点开展医生主导的性健康沟通。
- 沟通内容可侧重降风险治疗的性健康后果及维持性欲与亲密关系的策略。
- 避免在致病性变异诊断时强行讨论性健康,因部分患者认为过于沉重。
局限性
- 单中心横断面调查,样本量75例,结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patients with hereditary breast and ovarian cancer syndromes are frequently recommended risk-reducing salpingo-oophorectomy years before natural menopause. While effective in reducing cancer-related morbidity and mortality, salpingo-oophorectomy increases the risk of sexual dysfunction. This study explores patient experiences and perspectives on integrating sexual health support within hereditary cancer syndrome care. METHODS: From 02/2023-11/2023, we conducted a cross-sectional survey study at a gynecologic oncology clinic. Patients at increased genetic risk for breast and ovarian cancer completed a 26-question survey adapted from previous literature. Descriptive and univariate analyses were performed. RESULTS: Of 81 patients approached, 75 (93 %) participated. Median age was 42 years (IQR 13.5); 46 (61 %) had prior risk-reducing surgery, and 22 (29 %) had history of breast cancer. Sixty-six (88 %) reported that sexuality and intimacy were important and 57 (76 %) felt these issues should be addressed by the healthcare team. Sixty (80 %) preferred discussing sexual health with a physician. Patients welcomed discussions at multiple timepoints, including before risk-reducing surgery (46, 61 %) and during follow-up (67, 89 %). Twenty-six (35 %) felt it was too overwhelming to address sexual health at the time of pathogenic variant diagnosis. Key interests included consequences of risk-reducing treatments (58, 77 %) and strategies for maintaining sexuality and intimacy (49, 65 %). CONCLUSION: Sexual health is a significant concern for patients with hereditary breast and ovarian cancer risk. Most prefer physician-led conversations throughout different stages of care. These findings underscore the importance of a proactive, patient-centered approach to sexual health communication in this population.
引用
- Perez L, Kulkarni A, Lopez S, et al. Understanding patient priorities: Sexual health and hereditary ovarian cancer syndromes. Gynecol Oncol. 2026. PMID: 41619425. doi:10.1016/j.ygyno.2025.12.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。